ATP released by LPS increases nitric oxide production in raw 264.7 macrophage cell line via P2Z/P2X7 receptors

Neurochemistry International

Volumn 33, Issue 3, 1998, Pages 209-215

  Sperlágh, Beáta ^a   Haskó, György ^a   Németh, Zoltán ^a   Vizi, E Sylvester ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYLTHIOADENOSINE TRIPHOSPHATE; 3' O (4 BENZOYLBENZOYL)ADENOSINE TRIPHOSPHATE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE DERIVATIVE; BACTERIUM LIPOPOLYSACCHARIDE; CELL SURFACE RECEPTOR; LUCIFERASE; LUCIFERIN; NITRATE; NITRIC OXIDE; NITRITE; PURINE P2 RECEPTOR; PURINE P2X RECEPTOR; PURINE P2X7 RECEPTOR; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ADENOSINE TRIPHOSPHATE; ANIMALS; CELL LINE; CELL SURVIVAL; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MITOCHONDRIA; NITRIC OXIDE; OXIDATION-REDUCTION; OXYGEN CONSUMPTION; RECEPTORS, PURINERGIC P2;

EID: 0032168506     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(98)00025-4     Document Type: Article

References (45)

1. Ballerini, P., Rathbone M.P., Di Iorio, P., Renetti, A., Giuliani, O., D'Alimente, I., Trubiani, O., Caciagli, F., Ciccarelli, R., 1996. Rat astroglial P2Z (P2X7) receptors regulate intercellular calcium and purine release. Neuroreport 7, 2533-2537.
2. Blanchard, D.K., McMillen, S., Djeu J.Y., 1991. IFN-γ enhances sensitivity of human macrophages to extracellular ATP-mediated lysis. J. Immunol. 147, 1579-2585
3. Boeynaems, J.M., Pearson J.D., 1990. P2 purinoceptors on vascular endothelial cells: physiological significance and transduction mechanisms. Trends Pharmacol.Sci. 11,34-37.
4. Chessell, I.P., Michel, A.D., Humphrey, P.P.A., 1997. Properties of the poreforming P2X7 purinoceptor in mouse NTW8 microglial cells. Br. J. Pharmacol. 121, 1429-1437.
5. Chiozzi, P., Margia, M., Falzoni S., Ferrari D. and Di Virgilio F., 1996. Role of the purinergic P2Z receptor in spontaneous cell death in J774 macrophage cultures. Biochem. Biophys. Res. Comm. 218, 176-181.
6. Collo G., Neidhart, S., Kawashima E., Kosco-Vilbbois M., North R.A., Buell G., 1997. Tissue distribution of the P2X7 receptor. Neuropharmacol. 36, 1277-1285.
7. Cronstein B.N., 1994. Adenosine an endogenous anti-inflammatory agent. J. Appl. Physiol. 76, 5-13.
8. Denlinger, L., Fisette, P.L., Garis K.A., Kwom, G., Vasquez-Torres, A., Simon, A.D., Nguyen, B., Proctor, R.A., Bertics, P.J., Corbett, J.A., 1996. Regulation of inducible nitric oxide synthase expression by macrophage purinoceptors and calcium. J. Biol. Chem. 271, 337-342.
9. Di Virgilio, F., 1995. The P2Z purinoceptor: an intriguing role in immunity, inflammation and cell death. Immunology Today 16, 524-528.
10. Di Virgilio, P., Ferrari, D., Chiozzi, P., Falzoni, S., Sanz, J.M., dal Susino, M., Mutini, C., Hanau, S., Baricordi O.R., 1996. Purinoceptor function in the immune system. Drug Dev. Res. 39, 319-329.
11. Dubyak, G.R., El-Moatassim, C., 1995. Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides. Am. J. Physiol. 265, C577-C606.
12. El-Moatassim C., Dubyak, G.R., 1993. Dissociation of the pore-forming and phospholipase D activities stimulated via P2Z purinergic receptors in FAC1.2F5 macrophages. Product inhibition of phospholipase D enzyme activity. J. Biol. Chem. 268, 15571-15578.
13. Elenkov, I., Vizi, E.S., 1991. Presynaptic modulation of release of noradrenaline from the sympathetic nerve terminals in the rat spleen. Neuropharmacol. 30, 1319-1324.
14. Falzoni, S., Munerati, M., Melchiorri, L., Hanau, S., Di Virgilio, F., Baricordi O.R., 1995. The purinergic P2Z receptor of human macrophage cells. Characterization and possible physiological role. J. Clin. Invest. 95, 1207-1216.
15. Ferrari, D., Munerati, M., Melchiorri, L., Hanau, D., Di Virgilio, F., Baricordi O.R., 1994. Responses to extracellular ATP of lymphoblastoid cell lines from Duchenne muscular dystrophy patients. Am. J. Physiol. 267, C886-C892.
16. Ferrari, D., Chiozzi, P., Falzoni S., dal Susino, M., Collo, G., Buell, G., Di Virgilio, F., 1997a. ATP-mediated cytotoxicity in microglial cells. Neuropharmacol. 36, 1295-1303.
17. Ferrari, D., Chiozzi, P., Falzoni, S., dal Susino, M., Melchiorri, L., Daricordi, O.R., Di Virgilio, F., 1997b. Extracellular ATP triggers IL-!beta release by activating the purinergic P2Z receptor of human macrophages. J. Immunol. 159, 1451-1458.
18. Ferrari, D., Chiozzi, P., Falzoni, S., Hanau S., Di Virgilio, F., 1997c. Purinergic modulation of interleukin-1beta release from microglial cells stimulated with bacterial endotoxin. J. Exp. Med. 185, 579-582.
19. Ferrari, D., Wesselborg, S., Bauer, M.K.A., Schulze-Osthoff, K., 1997d. Extracellular ATP activates transcription factor NF-κB through the P2Z purinoceptor by selectively targeting NF-κB p65 (Re1A)., J. Cell. Biol. 1635-1643.
20. Filippini, A., Taffs, R.F., Sitkvsky, M.V., 1990. Extracellular ATP in T-lymphocyte activation: possible role in effector functions. Proc. Natl. Acad. Sci. U.S.A. 87, 8267-8271.
21. Fisette, P.L., Denlinger, L.C., Proctor, R.A., Bertics, P.J., 1996. Modulation of macrophage function by P2Y-purinergic receptors. Drug Dev. Res. 39, 377-387.
22. Haskó Gy., Szabó Cs., Németh, Z., Kvetan, V., McCarthy-Pastores, S., Vizi, E.S., 1996. Adenosine agonists differentially regulate IL-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice, J. Immunol. 157, 4634-4640.
23. Hon, W.M., Khoo, H.E., Ngoi, S.S., Moochala, S., 1995. Effects of adenosine receptor agonists on nitric oxide release in mouse during endotoxaemia. Biochem. Pharmacol. 50, 45-47.
24. Humphreys, B.D., Dubyak, G.R., 1996. Induction of the P2Z/P2X7 nucleotide receptor and associated phospholipase D activity by lipopolysaccharide and IFN-gamma in the human THP-1 monocytic cell line. J. Immunol. 157, 5627-5637.
25. Illés, P., Nieber, K., Frohich, R., Nörenberg, W., 1996. P2 purinoceptors and pyrimidinoceptors of catecholamine-producing cells and immunocytes. In: Chadwick, D.J., Goode, J.A., (Eds.), P2 purinoceptors: localization, function and transduction mechanisms. John Wiley and Sons, Chichester, 1996. pp. 11-129.
26. Jamieson, G.P., Snook, M.B., Thurlow, P.J., Wiley J.S., 1996. Extracellular ATP causes of loss of L-selectin from human lymphocytes via occupancy of P2Z purinoceptors. J. Cell. Physiol. 166, 637-642.
27. Lammas, D.A., Stober, C., Harvey, C.J., Kendrick, N., Panchalingam, S., Kumaratne D.S., 1997. ATP-induced killing of mycobacteria by human macrophages is mediated by purinergic P2Z(P2X7) receptors. Immunity 7, 433-444.
28. Markwandt, F., Löhn, M., Böhm, T., Klapperstuck, M., 1997. Pur-inoceptor-operated cationic channels in human B lymphocytes. J. Physiol. (Lond) 498, 143-151.
29. Murgia, M., Pizzo, P., Steinberg, T.H., Di Virgilio, F., 1992. Characterization of the cytotoxic effect of extracellular ATP in J774 macrophages. Biochem. J. 288, 897-901.
30. Osipchuk, Y., Cahalan, M., 1992. Cell-to-cell spread of calcium signals mediated by ATP receptors in mast cells. Nature 359, 241-244.
31. Rassendren, F., Buell, G.N., Virginio, C., Collo, G., North, R.A., Suprenant, A., 1997. The permeabilizing ATP receptor P2X7. J. Biol. Chem. 272, 5482-5486.
32. Sperlágh, B., Kittel, A., Lajtha, A., Vizi, E.S., 1995. ATP acts as fast neurotransmitter in rat habenula: neurochemical and enzyme-cytochemical evidence. Neurosci. 66, 915-920.
33. Sperlágh, B., Vizi, E.S., 1996. Neuronal synthesis, storage and release of ATP. Semin. Neurosci. 8, 175-186.
34. Steinberg, T.H., Newman, A.S., Swanson, J.A., Silverstein, S.C., 1987. ATP4-permeabilizes the plasma membrane of mouse macrophages to fluorescent dyes. J. Biol. Chem. 262, 8884-8888.
35. Suprenant, A., Rassendren, F., Kawashima, E., North, R.A., Buell, G., 1996. The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor. Science 272, 735-738.
36. Szabó C., Thiemermann, C., Vane, J.R., 1993a. Dihydropyridine antagonists and agonists of calcium channels inhibit the induction of nitric oxide synthase by endotoxin in cultured macrophages. Diochem. Biophys. Res. Comm. 196, 825-830.
37. Szabó C., Wu, C.C., Gross, S.S., Thiemermann, C., Perretti, M., Vane, J.R., 1993b. Interleukin-1 contributes to the induction of nitric oxide synthase by endotoxin in vivo. Eur. J. Pharmacol. 250, 157-160.
38. Szabó C., 1995. Alterations in the production of nitric oxide in various forms of circulatory shock. New Horiz. 3, 2-32.
39. Szabó C., 1996. Physiological and pathophysiological roles of nitric oxide in the central nervous system. Brain Res. Bull. 41, 131-141.
40. Szabó C., Zingarelli, B., O'Connor, M., Salzman, A.L., 1996. DNA strand breakage, activation of poly-ADP ribosyl synthetase and cellular energy depletion are involved in the cytotoxicity in macrophages and smooth muscle cells exposed to peroxynitrite. Proc. Natl. Acad. Sci. U.S.A. 93, 1753-1758.
41. Tonetti, M., Sturla, M., Bistolfi, T., Benatti, U., DeFlora, A., 1994. Extracellular ATP potentiates nitric oxide synthase expression induced by lipopoysaccharide in RAW 264.7 murine macrophages. Biochem. Biophys. Res. Comm. 203, 430-435.
42. Tonetti, M., Sturla, L., Giovina, M., Benattia, U., De Flora, A., 1995. Extracellular ATP enhances mRNA levels of nitric oxide synthase and TNF-alpha in lipopolisaccharide-treated RAW 264.7 murine macrophages. Biochem. Biophys. Res. Comm. 214, 125-130.
43. Virginio, C., Church, D., North, R.A., Suprenant, A., 1997. Effect of divalent cations, protons and calmidazolium at the rat P2X7 receptor. Neuropharmacol. 36,1285-1295.
44. Vizi, E.S., Orso, E., Osipenko, O.N., Haskó G., Elenkov, I.J., 1995.Neurochemical, electrophysiological and immunocytochemical evidence for a noradrenergic link between the sympathetic nervous system and thymocytes. Neurosci. 68, 1263-1276.
45. Wiley, J.S., Chen, J.R., Snook, M.B., Jamieson, G.P., 1994. The P2Z-purinoceptor of human lymphocytes: actions of nucleotide agonists and irreversible inhibition by oxidized ATP. Br. J. Pharmacol. 112, 946-950.